(firstQuint)Efficacy and Safety Study of Ticagrelor.

 180 elective percutaneous coronary intervention patients with clopidogrel resistance were randomized to three groups, Group 1:received clopidogrel 75mg qd ;Group 2:received clopidogrel 150mg qd ; Group 3:received ticagrelor 90mg bid after PCI.

Platelet funtion were tested by flowcytometric vasodilator-stimulated phosphoprotein(VASP) analysis before PCI,and 3days,7days and 1 month after PCI,respectively.

The aim of our study is to compare the efficacy and safety of ticagrelor with clopidogrel.

 Efficacy and Safety Study of Ticagrelor@highlight

The purpose of this study is to compare the efficacy and safety of ticagrelor with clopidogrel